Blog

Hemophilia

Xyntha: Uses, Dosing, Side Effects, Storage, and Administration

Doctor talking to a boy and her mother about Xyntha

Xyntha is an FDA-approved prescription medication for adults and children with hemophilia A that replaces clotting factor VIII to help prevent and control bleeding. Hemophilia A (classic hemophilia) is an inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor VIII.

Get Financial Assistance

(877) 778-0318

Xyntha Introduction and Uses

Xyntha is a brand-name prescription product. The active ingredient in this product is recombinant antihemophilic factor (rAHF), which is also known as coagulation factor VIII or moroctocog alfa.

Xyntha belongs to a drug class called coagulation factors. 

A healthcare provider may prescribe this medication for children and adults with hemophilia A to:

  • Treat and control bleeding episodes as they occur
  • Manage bleeding before, during, and after surgery
  • Reduce the frequency of bleeding episodes through routine preventive treatment

Xyntha is not indicated for the treatment of von Willebrand disease (VWD).  

Xyntha comes as a white to off-white powder in single-use vials. Each vial contains 250, 500, 1,000, or 2,000 International Units (IU) of the active drug. 

Each Xyntha vial kit contains:

  • 4 ml 0.9% Sodium Chloride with plunger rod for assembly
  • One vial adapter
  • One sterile infusion set
  • Two alcohol swabs
  • One bandage
  • One gauze pad
  • One package insert

The powder must be mixed with the sodium chloride solution before intravenous (IV) infusion.

Mechanism of Action

People with hemophilia A have deficient or dysfunctional clotting factor VIII. Factor VIII plays an important role in the blood-clotting process, and a deficiency can lead to prolonged or spontaneous bleeding, including bleeding into the joints and muscles. 

Xyntha works by temporarily replacing the missing clotting factor VIII in the blood, helping the blood form clots and control bleeding.

Before Using Xyntha 

Before you receive your first dose of Xyntha, inform your healthcare provider if you are:

  • Allergic to Xyntha, any of its ingredients, or hamster proteins, which may be present in trace amounts
  • Pregnant or planning to become pregnant
  • Breastfeeding or planning to breastfeed

Important Xyntha Warnings

Allergic Reactions

This medicine may cause serious allergic reactions, including anaphylaxis. Anaphylaxis is a potentially life-threatening allergic reaction that can cause breathing problems, swelling, a rapid heartbeat, faintness, or low blood pressure. 

Stop using this medication and seek immediate medical care if you develop the following symptoms after receiving Xyntha:

  • Rash and itching
  • Hoarseness
  • Breathing difficulty
  • Trouble swallowing
  • Swelling of your hands, face, or mouth
  • Chest tightness
  • Low blood pressure

Get Copay Assistance Now

Get Started

Factor VIII Inhibitor Development 

Some people can develop antibodies called factor VIII inhibitors, which may reduce or prevent Xyntha from working effectively. 

Your healthcare provider may order blood tests to check for factor VIII inhibitors if: 

  • Your factor VIII levels do not increase as expected after treatment
  • Bleeding is not controlled with an appropriate dose

Dosing

Your healthcare provider will calculate your dose based on your body weight, desired increase in factor VIII activity, clinical response, and treatment needs. Always use the dose prescribed specifically for you.

The dose and duration of treatment depend on:

  • The severity of the factor VIII deficiency
  • The location and extent of bleeding
  • The type of bleeding episode or surgery
  • Your clinical condition and response to treatment

Dosing for On-Demand Treatment and Control of Bleeding Episodes

Minor bleeding: The dose is individualized to achieve a factor VIII activity level of approximately 20% to 40% of normal. Treatment may be repeated every 12 to 24 hours for at least 1 day, depending on the severity of bleeding.

Moderate bleeding: The dose is individualized to achieve a factor VIII activity level of approximately 30% to 60% of normal. Treatment may be repeated every 12 to 24 hours for 3 to 4 days or until bleeding is adequately controlled. 

Major bleeding: The dose is individualized to achieve a factor VIII activity level of approximately 60% to 100% of normal. Treatment may be repeated every 8 to 24 hours until the bleeding is controlled. 

Dosing for Preventing Bleeding During Surgery

Minor surgery: The dose is individualized to achieve a factor VIII activity level of approximately 30% to 60% of normal. Treatment may be repeated every 12 to 24 hours as directed by the healthcare provider.

Major surgery: The dose is individualized to achieve a factor VIII activity level of approximately 60% to 100% of normal. Treatment may be repeated every 8 to 14 hours until adequate wound healing is achieved. 

Dosing for Routine Prevention of Bleeding Episodes 

Recommended starting regimens include:

  • Adults and adolescents 12 years or older: 30 IU/kg IV three times weekly
  • Children younger than 12 years: 25 IU/kg IV every other day

Children younger than 12 may require higher or more frequent doses because the medication may be cleared from their bodies more quickly.

Your healthcare provider will adjust the dose or frequency based on your bleeding pattern, factor VIII levels, and clinical response.

Speak to a Specialist

About Copay Assistance
(877) 778-0318

Side Effects

Common side effects reported with Xyntha include:

Boy suffering from headaches, a side effect of taking Xyntha
  • Nausea, vomiting, diarrhea
  • Headache
  • Dizziness
  • Joint pain
  • Rash
  • Sore throat
  • Cough
  • Stuffy nose
  • Weakness
  • Tiredness
  • Fever
  • Pain, swelling, or itching at the injection site

Serious risks of Xyntha include severe allergic reactions and the development of factor VIII inhibitors. Contact your healthcare provider if bleeding is not adequately controlled after receiving Xyntha or if you experience an increase in bleeding episodes. These may be signs that factor VIII inhibitors have developed.

Seek immediate medical attention if you experience symptoms of a serious allergic reaction, such as difficulty breathing, chest tightness, swelling of the face or mouth, or severe dizziness or fainting.

Xyntha Administration and Proper Use 

Use Xyntha exactly as prescribed by your healthcare provider. You may receive your first dose in a hospital, clinic, or treatment center. If home treatment is appropriate, your healthcare provider will teach you how to prepare and administer the medication safely.

  • Read and follow the Instructions for Use included with the product
  • Wash your hands and work on a clean surface
  • Allow the kit to reach room temperature
  • Use only the supplies provided with Xyntha or recommended by your healthcare provider 
  • Inspect the reconstituted solution before infusion; it should be clear to slightly opalescent and colorless 
  • Do not use the solution if it contains particles or appears discolored

Contact your healthcare provider immediately if:

  • Bleeding is not controlled after treatment
  • You administer more than your prescribed dose
  • You have difficulty preparing or infusing the medication

Before traveling, speak with your healthcare provider and bring enough medication and infusion supplies for the entire trip.

Xyntha Storage and Handling

  • Store unopened Xyntha in a refrigerator at 2°C to 8°C (36°F to 46°F) for up to 36 months from the date of manufacture, but not beyond the labeled expiration date. 
  • Within the labeled expiration period, the medication may be stored at room temperature no higher than 25°C (77°F) for up to 3 months.
  • Record the date room-temperature storage begins in the space provided on the carton.
  • After 3 months at room temperature, use the medication immediately or discard it.
  • Do not return the medication to the refrigerator after it has been stored at room temperature.
  • Do not use the medication after its labeled expiration date or after 3 months at room temperature, whichever occurs first.
  • Do not freeze Xyntha.
  • Protect it from prolonged exposure to light.
  • After reconstitution, keep the syringe upright at room temperature until use.
  • Infuse the reconstituted solution within 3 hours after reconstitution or after removing the gray rubber tip cap.
  • Discard the reconstituted solution if it has not been used within 3 hours.

Connect With a Copay Assistance Specialist

Get Started

Cost and Financial Assistance

Cost can vary depending on your insurance plan, location, and pharmacy. Contact your insurance provider to find out if your plan covers this medication or if you need prior authorization. If cost is a concern, contact us to learn more about financial or copay assistance for Xyntha.

This information is not a substitute for medical advice or treatment. Talk to your doctor or healthcare provider about your medical condition prior to starting any new treatment. AmeriPharma® Specialty Care assumes no liability whatsoever for the information provided or for any diagnosis or treatment made as a result, nor is it responsible for the reliability of the content. AmeriPharma® Specialty Care does not operate all the websites/organizations listed here, nor is it responsible for the availability or reliability of their content. These listings do not imply or constitute an endorsement, sponsorship, or recommendation by AmeriPharma® Specialty Care. This webpage may contain references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with AmeriPharma® Specialty Care.
Dr. Mark Alfonso
MEDICALLY REVIEWED BY Dr. Mark Alfonso, PharmD, BCMTMS

Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.

Contact Us

If you are interested in speaking to a specialist or wish to explore financial assistance opportunities, use the contact form below to get in touch with us.

HIPAA Compliant

By submitting, you agree to AmeriPharma’s Terms of Use, Privacy Policy, and Notice of Privacy Practices